ArticleTranslational lung cancer research2021

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease.

Yusuke Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.